GB9402203D0
(en)
*
|
1994-02-04 |
1994-03-30 |
Smithkline Beecham Plc |
Pharmaceutical formulation
|
GB9416600D0
(en)
*
|
1994-08-17 |
1994-10-12 |
Smithkline Beecham Plc |
Pharmaceutical formulation
|
US20030109503A1
(en)
*
|
1995-06-06 |
2003-06-12 |
Smithkline Beecham P.L.C. |
Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
|
DE69617036T2
(de)
|
1995-09-07 |
2002-07-11 |
Smithkline Beecham Corp |
Verwendung einer amoxicillin und clavulanat enthaltenden paediatrischen pharmazeutischen formulierung
|
US8071128B2
(en)
|
1996-06-14 |
2011-12-06 |
Kyowa Hakko Kirin Co., Ltd. |
Intrabuccally rapidly disintegrating tablet and a production method of the tablets
|
AUPS270602A0
(en)
|
2002-05-31 |
2002-06-20 |
Baron, Peter |
Drink flavouring straw
|
US20030087005A1
(en)
*
|
1996-10-10 |
2003-05-08 |
Peter Baron |
Drink flavouring straw
|
EA002595B1
(ru)
*
|
1997-02-14 |
2002-06-27 |
Смитклайн Бичем Лаборатуар Фармасетик |
Фармацевтический препарат, содержащий амоксициллин и клавуланат, способ его приготовления и гранулят, содержащий амоксициллин и клавуланат
|
US20030124187A1
(en)
*
|
1997-02-14 |
2003-07-03 |
Smithkline Beecham Laboratoires Pharmaceutiques, |
Pharmaceutical formulations comprising amoxycillin and clavulanate
|
ATE250929T1
(de)
*
|
1997-05-30 |
2003-10-15 |
Osmotica Corp |
Mehrlagige osmosevorrichtung
|
KR100502478B1
(ko)
*
|
1997-06-13 |
2005-12-02 |
동아제약주식회사 |
클라불란산과베타락탐계항생물질을포함하는세균감염증치료제용약학적조성물
|
US20090060995A1
(en)
*
|
2005-01-13 |
2009-03-05 |
Kamalinder Kaur Singh |
Dispersible sustained release pharmaceutical compositions
|
US6294199B1
(en)
|
1999-04-13 |
2001-09-25 |
Beecham Pharmaceuticals (Pte) Limited |
Method of treating a bacterial infection comprising administering amoxycillin
|
CO5170471A1
(es)
*
|
1999-04-13 |
2002-06-27 |
Beecham Pharmaceutical Pte Ltd |
Tabletas de liberacion modificada que incluyen amoxilina y clavulanato de potasio
|
US7250176B1
(en)
*
|
1999-04-13 |
2007-07-31 |
Beecham Pharmaceuticals (Pte) Limited |
Method of treating a bacterial infection
|
US6878386B1
(en)
|
1999-04-13 |
2005-04-12 |
Beecham Pharmaceuticals (Pte) Limited |
Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
|
EP1265599A4
(de)
*
|
2000-02-24 |
2006-01-18 |
Advancis Pharmaceutical Corp |
Antibiotische zubereitung mit hemmstoff
|
WO2001062231A1
(en)
*
|
2000-02-24 |
2001-08-30 |
Advancis Pharmaceutical Corporation |
Antibiotic composition with inhibitor
|
US6544555B2
(en)
*
|
2000-02-24 |
2003-04-08 |
Advancis Pharmaceutical Corp. |
Antibiotic product, use and formulation thereof
|
US6565882B2
(en)
*
|
2000-02-24 |
2003-05-20 |
Advancis Pharmaceutical Corp |
Antibiotic composition with inhibitor
|
US7838032B2
(en)
|
2000-04-28 |
2010-11-23 |
Reckitt Benckiser Inc. |
Sustained release of guaifenesin
|
US6955821B2
(en)
|
2000-04-28 |
2005-10-18 |
Adams Laboratories, Inc. |
Sustained release formulations of guaifenesin and additional drug ingredients
|
US7985420B2
(en)
|
2000-04-28 |
2011-07-26 |
Reckitt Benckiser Inc. |
Sustained release of guaifenesin combination drugs
|
US8012504B2
(en)
|
2000-04-28 |
2011-09-06 |
Reckitt Benckiser Inc. |
Sustained release of guaifenesin combination drugs
|
EP1330236A2
(de)
|
2000-10-12 |
2003-07-30 |
Beecham Pharmaceuticals (Pte) Limited |
Amoxicillinhaltige arzneizusammensetzungen
|
US6756057B2
(en)
|
2000-10-12 |
2004-06-29 |
Beecham Pharmaceuticals (Pte) Limited |
Amoxicillin and potassium clavulanate dosage form
|
US6541014B2
(en)
*
|
2000-10-13 |
2003-04-01 |
Advancis Pharmaceutical Corp. |
Antiviral product, use and formulation thereof
|
GB0025208D0
(en)
*
|
2000-10-13 |
2000-11-29 |
Euro Celtique Sa |
Delayed release pharmaceutical formulations
|
US20020068078A1
(en)
|
2000-10-13 |
2002-06-06 |
Rudnic Edward M. |
Antifungal product, use and formulation thereof
|
US20020197314A1
(en)
*
|
2001-02-23 |
2002-12-26 |
Rudnic Edward M. |
Anti-fungal composition
|
US20030143272A1
(en)
*
|
2001-03-14 |
2003-07-31 |
Waterman Kenneth C. |
Pharmaceutical tablet and process for making thereof
|
ATE330586T1
(de)
*
|
2001-03-14 |
2006-07-15 |
Pfizer Prod Inc |
Pharmazeutische tablette und eine verfahren zu deren herstellung
|
US9358214B2
(en)
|
2001-10-04 |
2016-06-07 |
Adare Pharmaceuticals, Inc. |
Timed, sustained release systems for propranolol
|
US7560123B2
(en)
*
|
2004-08-12 |
2009-07-14 |
Everett Laboratories, Inc. |
Compositions and methods for nutrition supplementation
|
KR100540035B1
(ko)
*
|
2002-02-01 |
2005-12-29 |
주식회사 태평양 |
다단계 경구 약물 방출 제어 시스템
|
WO2003096874A2
(en)
*
|
2002-05-15 |
2003-11-27 |
Sun Pharmaceutical Industries Limited |
Coated sustained release tablets of a hygroscopic compound for once-a-day therapy
|
KR100456833B1
(ko)
*
|
2002-08-01 |
2004-11-10 |
주식회사 대웅 |
아목시실린 및 클라불라네이트를 함유하는 유핵정
|
ES2358896T3
(es)
*
|
2002-08-15 |
2011-05-16 |
Euro-Celtique S.A. |
Composiciones farmacéuticas que comprenden un analgésico opioide.
|
US6803046B2
(en)
|
2002-08-16 |
2004-10-12 |
Bracco International B.V. |
Sincalide formulations
|
US8617617B2
(en)
*
|
2002-12-10 |
2013-12-31 |
Everett Laboratories, Inc. |
Methods and kits for co-administration of nutritional supplements
|
US6814983B2
(en)
*
|
2002-12-10 |
2004-11-09 |
Everett Laboratories, Inc. |
Compositions and methods for nutrition supplementation
|
US8367111B2
(en)
|
2002-12-31 |
2013-02-05 |
Aptalis Pharmatech, Inc. |
Extended release dosage forms of propranolol hydrochloride
|
EA011215B1
(ru)
*
|
2003-02-21 |
2009-02-27 |
Лек Фармасьютиклз Д.Д. |
Терапевтическая система, содержащая амоксициллин и клавулановую кислоту, плавающая капсула
|
MXPA05011724A
(es)
*
|
2003-05-02 |
2006-01-23 |
Warner Lambert Co |
Productos dulces para liberar agentes farmaceuticamente activos a la garganta.
|
CA2533178C
(en)
*
|
2003-07-21 |
2014-03-11 |
Advancis Pharmaceutical Corporation |
Antibiotic product, use and formulation thereof
|
WO2005009364A2
(en)
*
|
2003-07-21 |
2005-02-03 |
Advancis Pharmaceutical Corporation |
Antibiotic product, use and formulation thereof
|
CA2533292C
(en)
*
|
2003-07-21 |
2013-12-31 |
Advancis Pharmaceutical Corporation |
Antibiotic product, use and formulation thereof
|
WO2005016311A1
(en)
*
|
2003-08-11 |
2005-02-24 |
Advancis Pharmaceutical Corporation |
Robust pellet
|
AU2004264356B2
(en)
*
|
2003-08-12 |
2011-01-27 |
Shionogi, Inc. |
Antibiotic product, use and formulation thereof
|
JP5686494B2
(ja)
*
|
2003-08-29 |
2015-03-18 |
シオノギ インコーポレイテッド |
抗生物質製剤、その使用法及び作成方法
|
EP1663169A4
(de)
*
|
2003-09-15 |
2010-11-24 |
Middlebrook Pharmaceuticals In |
Antibiotisches produkt, seine verwendung und formulierung
|
NZ546148A
(en)
|
2003-09-26 |
2009-05-31 |
Alza Corp |
Drug coating providing high drug loading and methods for providing the same
|
NZ546183A
(en)
*
|
2003-09-26 |
2011-04-29 |
Alza Corp |
Controlled release formulations exhibiting an ascending rate of release
|
US20070122480A1
(en)
*
|
2003-09-29 |
2007-05-31 |
Cj Corporation |
Sustained release formulations
|
AU2004308419B2
(en)
*
|
2003-12-24 |
2011-06-02 |
Victory Pharma, Inc. |
Enhanced absorption of modified release dosage forms
|
TW200534879A
(en)
*
|
2004-03-25 |
2005-11-01 |
Bristol Myers Squibb Co |
Coated tablet formulation and method
|
US20050256314A1
(en)
*
|
2004-05-04 |
2005-11-17 |
Soojin Kim |
Process employing controlled crystallization in forming crystals of a pharmaceutical
|
US7829720B2
(en)
|
2004-05-04 |
2010-11-09 |
Bristol-Myers Squibb Company |
Process for preparing atazanavir bisulfate and novel forms
|
US20050288343A1
(en)
*
|
2004-05-19 |
2005-12-29 |
Andrew Rusowicz |
Process of preparing substituted carbamates and intermediates thereof
|
TWI354569B
(en)
*
|
2004-05-28 |
2011-12-21 |
Bristol Myers Squibb Co |
Coated tablet formulation and method
|
JP2008505124A
(ja)
*
|
2004-07-02 |
2008-02-21 |
アドバンシス ファーマスーティカル コーポレイション |
パルス送達用錠剤
|
DE102004035938A1
(de)
*
|
2004-07-23 |
2006-02-16 |
Röhm GmbH & Co. KG |
Verfahren zur Herstellung von überzogenen Arzneiformen mit stabilem Wirkstofffreigabeprofil
|
KR100638315B1
(ko)
*
|
2004-07-23 |
2006-10-25 |
주식회사 대웅제약 |
다중 필름 코팅된 코어층을 갖는 클라불라네이트 및아목시실린-함유 유핵정
|
US8101587B2
(en)
|
2004-08-12 |
2012-01-24 |
Everett Laboratories, Inc. |
Kits for nutrition supplementation
|
US8747895B2
(en)
|
2004-09-13 |
2014-06-10 |
Aptalis Pharmatech, Inc. |
Orally disintegrating tablets of atomoxetine
|
US8541026B2
(en)
|
2004-09-24 |
2013-09-24 |
Abbvie Inc. |
Sustained release formulations of opioid and nonopioid analgesics
|
US9884014B2
(en)
|
2004-10-12 |
2018-02-06 |
Adare Pharmaceuticals, Inc. |
Taste-masked pharmaceutical compositions
|
NZ589750A
(en)
|
2004-10-21 |
2012-07-27 |
Aptalis Pharmatech Inc |
Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
|
US9161918B2
(en)
|
2005-05-02 |
2015-10-20 |
Adare Pharmaceuticals, Inc. |
Timed, pulsatile release systems
|
WO2007065559A1
(en)
*
|
2005-11-18 |
2007-06-14 |
Synthon B.V. |
Zolpidem tablets
|
WO2007059916A2
(en)
*
|
2005-11-23 |
2007-05-31 |
Sandoz Ag |
Pharmaceutical composition
|
US8778924B2
(en)
*
|
2006-12-04 |
2014-07-15 |
Shionogi Inc. |
Modified release amoxicillin products
|
US8357394B2
(en)
|
2005-12-08 |
2013-01-22 |
Shionogi Inc. |
Compositions and methods for improved efficacy of penicillin-type antibiotics
|
AR060029A1
(es)
|
2006-03-02 |
2008-05-21 |
Unistraw Patent Holdings Ltd |
Pajilla para beber adaptada para acondicionar progresivamente un ingrediente activo y metodo de fabricar dicha pajilla
|
BRPI0708640A8
(pt)
*
|
2006-03-06 |
2018-04-24 |
Pozen Inc |
composição farmacêutica, e, métodos para tratar um paciente com dor de cabeça de enxaqueca, para tratar um paciente com dor e para tratar um paciente com enxaqueca
|
US9265732B2
(en)
|
2006-03-06 |
2016-02-23 |
Pozen Inc. |
Dosage forms for administering combinations of drugs
|
US8299052B2
(en)
|
2006-05-05 |
2012-10-30 |
Shionogi Inc. |
Pharmaceutical compositions and methods for improved bacterial eradication
|
US8765178B2
(en)
*
|
2006-07-19 |
2014-07-01 |
Watson Laboratories, Inc. |
Controlled release formulations and associated methods
|
WO2008029351A2
(en)
*
|
2006-09-04 |
2008-03-13 |
Ranbaxy Laboratories Limited |
A modified release formulation comprising amoxicillin and clavulanate
|
EA018036B1
(ru)
|
2006-11-27 |
2013-05-30 |
Х. Лундбекк А/С |
Гетероариламидные производные
|
US20100183716A1
(en)
*
|
2007-06-22 |
2010-07-22 |
Bristo-Meyers Squibb Company |
Tableted compositions containing atazanavir
|
DK2170292T3
(da)
*
|
2007-06-22 |
2014-04-07 |
Bristol Myers Squibb Holdings Ireland |
Atazanavirholdige sammensætninger i tabletform
|
DE602008005462D1
(de)
*
|
2007-06-22 |
2011-04-21 |
Bristol Myers Squibb Co |
Tablettierte atazanavirhaltige zusammensetzungen
|
WO2009002823A2
(en)
*
|
2007-06-22 |
2008-12-31 |
Bristol-Myers Squibb Company |
Tableted compositions containing atazanavir
|
US20100034968A1
(en)
*
|
2008-08-07 |
2010-02-11 |
Vector Corporation |
Polymer coating process using dry glidant in a rotor processor
|
US8807070B2
(en)
*
|
2008-08-07 |
2014-08-19 |
Vector Corporation |
Rotor processor for dry powders
|
EP3427750A1
(de)
|
2009-05-12 |
2019-01-16 |
The Government of The United States of America as represented by The Secretary, Department of Health and Human Services |
Neue humane rotavirenstämme und impfstoffe
|
US8709477B2
(en)
*
|
2009-08-13 |
2014-04-29 |
Kremers Urban Pharmaceuticals, Inc` |
Pharmaceutical dosage form
|
US9173860B2
(en)
*
|
2009-11-04 |
2015-11-03 |
Susan Park Perrine |
S isomers of α-methyl hydrocinnamic acid for the treatment of blood disorders
|
JP5309262B2
(ja)
|
2009-12-02 |
2013-10-09 |
アプタリス ファーマ リミテッド |
フェキソフェナジン・マイクロカプセル及びそれを含む組成物
|
WO2011071877A2
(en)
*
|
2009-12-07 |
2011-06-16 |
Mcneil-Ppc, Inc. |
Partial dip coating of dosage forms for modified release
|
EP2531224B1
(de)
|
2010-01-26 |
2019-06-05 |
Bioregency, Inc. |
Zusammensetzungen und verfahren im zusammenhang mit argininsuccinat-synthetase
|
RS60186B1
(sr)
|
2011-04-29 |
2020-06-30 |
Penn State Res Found |
Indukcija malog molekula trail genom u normalnim i tumorskim ćelijama kao antikancerska terapija
|
WO2012149452A1
(en)
|
2011-04-29 |
2012-11-01 |
Regents Of The University Of Michigan |
Compounds, formulations, and methods of protein kinase c inhibition
|
US8183227B1
(en)
|
2011-07-07 |
2012-05-22 |
Chemo S. A. France |
Compositions, kits and methods for nutrition supplementation
|
US8168611B1
(en)
|
2011-09-29 |
2012-05-01 |
Chemo S.A. France |
Compositions, kits and methods for nutrition supplementation
|
WO2013057569A2
(en)
*
|
2011-10-19 |
2013-04-25 |
Micro Labs Limited |
Extended release pharmaceutical composition containing amoxicillin and clavulanic acid
|
US9682093B2
(en)
|
2012-03-30 |
2017-06-20 |
Charles R. Drew University Of Medicine And Science |
Compositions and methods for treating or preventing metabolic syndrome disorders
|
CN105007940B
(zh)
|
2012-12-20 |
2017-08-25 |
宾夕法尼亚州研究基金会 |
与癌症治疗相关的方法和组合物
|
US20140271923A1
(en)
|
2013-03-14 |
2014-09-18 |
Christopher Brian Reid |
Compositions & formulations for preventing and treating chronic diseases that cluster in patients such as cardiovascular disease, diabetes, obesity, polycystic ovary syndrome, hyperlipidemia and hypertension, as well as for preventing and treating other diseases and conditions
|
US10716783B2
(en)
|
2013-12-12 |
2020-07-21 |
Cornell University |
Prolylhydroxylase/ATF4 inhibitors and methods of use for treating neural cell injury or death and conditions resulting therefrom
|
US11278506B2
(en)
|
2015-10-09 |
2022-03-22 |
Rb Health (Us) Llc |
Pharmaceutical formulation
|
US11110063B2
(en)
|
2017-08-25 |
2021-09-07 |
MAIA Pharmaceuticals, Inc. |
Storage stable sincalide formulations
|
US20190381056A1
(en)
|
2018-06-17 |
2019-12-19 |
Axsome Therapeutics, Inc. |
Compositions for delivery of reboxetine
|
US20200147093A1
(en)
|
2018-10-15 |
2020-05-14 |
Axsome Therapeutics, Inc. |
Use of esreboxetine to treat nervous system disorders such as fibromyalgia
|
US11020402B2
(en)
|
2018-10-15 |
2021-06-01 |
Axsome Therapeutics, Inc. |
Use of reboxetine to treat narcolepsy
|